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CHAPTER I 
 
INTRODUCTION 
 
Background and Significance 
Coronary artery disease remains one of the most significant causes of death in 
western societies despite rapid advances in medical technology and interventional 
treatments over the last 25 years (1). These treatments have been guided in large 
part by advances in medical imaging modalities such as echocardiography, 
computed tomography (CT), positron emission tomography (PET), and magnetic 
resonance imaging (MRI).  
 
MRI is a relatively new form of medical imaging relying on the application of 
electromagnetic principles to visualize anatomy and function. An external magnetic 
field can be used to generate a net magnetic moment in the sample to be imaged. 
Magnetic moments then align with that field and begin to precess about it. The 
angular frequency of precession scales linearly with the strength of the external 
field. Thus a stronger external field results in a faster precessional frequency. The 
interactions of nuclear magnetic moments may be harnessed for imaging purposes 
by clever application of magnetic field gradients and radiofrequency pulses.  A 
spatially varying magnetic field applied across a tissue sample will cause the 
moments to precess at different rates. By exciting the sample with a series of 
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radiofrequency (RF) pulses, the spins may be pushed out of alignment with the 
external field, synchronized, or otherwise manipulated to produce an RF field that 
can be measured in a receiving coil. This received signal may then be digitally 
processed by Fourier transform to produce an image (2). 
 
Image contrast in MRI is governed by the complex interactions of magnetization 
and tissue composition and structure. MRI systems can be used to measure the 
time constants that characterize these interactions in different tissue types and 
conditions. Recently developed high-field magnets, gradient systems, and coil 
technologies allow MRI to be used as a sophisticated diagnostic tool in a variety of 
clinical applications.  Of particular interest is the ability to use MRI to non-invasively 
probe cardiac tissue for myocardial infarction (MI) as a result of ischemia, to 
assess candidacy for reperfusion therapy, and to identify responses to stress 
agents.  
 
Two MRI methods have become viable alternatives to PET or SPECT for 
determining ischemia in myocardial tissue (3, 4). The first technique is generally 
referred to as delayed gadolinium (Gd) contrast hyperenhancement whereby 
several minutes after contrast injection, infarcted myocardium exhibits image 
enhancement due to gadolinium chelate accumulation (5-8). The second 
technique is blood oxygen level dependence (BOLD) imaging. This method relies 
on an endogenous source of contrast, the oxygen level dependence of the 
myocardial signal. The effects of local changes in tissue oxygenation in the 
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myocardial microvasculature are manifested in altered transverse relaxation rates 
(T2 and T2*) (9-12). For ischemic or infarcted tissue, the lack of adequate 
perfusion is evident in lower measured transverse relaxation rates as compared to 
regions of adequate oxygen supply (11, 13). Transverse relaxation variations due 
to normal perfusion gradients in these tissues have not been reported. 
 
Since the advent of clinical 3T MRI, the inherent signal to noise advantage has 
been much publicized as driving the future of clinical cardiac care (5,8). However, 
increased SAR restrictions, susceptibility artifacts, and standing waves pose 
challenges not apparent at 1.5T.  Much effort has been expended developing 
phased array coils, new sequence techniques, navigator gating, and other 
methods to mitigate the disadvantages of thoracic imaging at 3T. Most clinical 
imaging utilizes delayed contrast enhancement and SSFP cine techniques to 
confirm the functional status of the heart (6,8). However, these sequences are not 
directly applicable to measuring the myocardial BOLD effect. Applying the 
knowledge gained improving clinical high-field imaging towards improving 
myocardial BOLD imaging has not been reported.   
 
Several measurement approaches have been previously taken to measure BOLD 
effects in myocardium including gradient-echo (GRE) (9-11), spin-echo (SE) 
(14,15), and steady-state free precession (SSFP) based imaging techniques 
(13,16). Each approach attempts to maximize T2 or T2* BOLD contrast at a given 
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field strength while minimizing inherent disadvantages each technique carries with 
respect to artifacts and noise. 
   
Specific Aims 
The goal of the present work was to develop methods that overcome the practical 
difficulties of 3T human myocardial imaging and to determine reliable reference 
values for transverse relaxation times across normal human myocardium. It is of 
note that the typical protocol provided by the major MRI manufacturers for 
transverse relaxation mapping is a single 2-echo scan for in vivo measurement. 
Given only two data points to define an exponential decay, these 2-echo protocols 
may not allow for reliable measurements (17,18). With the goal of reliably 
measuring transverse relaxation for use in myocardial imaging, the following 
specific aims were developed.  
 
1. To test a series of multi-echo, breath-hold scans for the measurement of T2 
and T2* at 3 Tesla. 
2. To optimize T2 and T2* methods with sufficient resolution to distinguish 
endo- and epicardium. 
3. To evaluate the accuracy and repeatability of these methods.  
 
Achievement of these aims will enable reliable detection of subtle changes in 
tissue properties with good spatial resolution at high field, yielding new insight into 
basic questions about cardiac physiology. 
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CHAPTER II 
 
MEASURING TRANSVERSE RELAXATION IN MYOCARDIAL TISSUE WITH 3T 
MAGNETIC RESONANCE IMAGING 
 
Introduction 
Coronary artery disease remains one of the most significant causes of death in 
western societies despite rapid advances in medical technology and interventional 
treatments over the last 25 years (1). These treatments have been guided in large 
part by advances in medical imaging modalities such as echocardiography, 
computed tomography (CT), positron emission tomography (PET), and magnetic 
resonance imaging (MRI) that allow physicians to gather important information 
about cardiac function and disease state. 
 
Of particular interest is the ability to use MRI to non-invasively probe cardiac tissue 
for myocardial infarction (MI) as a result of ischemia, to assess candidacy for 
reperfusion therapy, and to identify responses to stress agents.  Currently PET and 
single photon emission tomography (SPECT) are advocated for these purposes; 
however each technique is limited by a relatively low spatial resolution as 
compared to MRI and carries a dose of ionizing radiation (3, 19). 
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Two MRI methods have become viable alternatives for determining ischemia in 
myocardial tissue (3,4). The first technique is generally referred to as delayed 
gadolinium (Gd) contrast hyperenhancement whereby several minutes after 
contrast injection, infarcted myocardium exhibits image enhancement due to 
gadolinium chelate accumulation (5-8). However, for patients with renal 
dysfunction, Gd is contraindicated due to the risk of nephrogenic systemic fibrosis 
(NSF) (20,21). In this case it would be advantageous to have an equivalent, non-
invasive test. Blood oxygen level dependence (BOLD) imaging fulfils this need by 
taking advantage of an endogenous source of contrast, the oxygen level 
dependence of the myocardial signal. The effects of local changes in tissue 
oxygenation in the myocardial microvasculature are manifest in altered transverse 
relaxation rates (T2 and T2*) (9-12). For ischemic or infarcted tissue, the lack of 
adequate perfusion is evident in lower measured signal as compared to regions of 
adequate oxygen supply (11,13). Transmural variations across the myocardium 
have been well characterized at 1.5 and 3T using first-pass T1-weighted imaging. 
These studies show regions of hypoperfusion in the free-wall endocardium due to 
increased contractile forces and to the smaller diameter of the feeding vessels (22, 
23). Transverse relaxation variations due to normal perfusion gradients in these 
tissues have not been reported. However preliminary studies have been done in 
infarcted tissue demonstrating the effects of reduced perfusion on transverse 
relaxation in ischemic tissue (11). 
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Several measurement approaches have been published reporting these BOLD 
effects in myocardium including: gradient-echo (GRE) (9-11), spin-echo (SE) 
(14,15), and steady-state free precession (SSFP) based imaging techniques 
(13,16). Each approach attempts to maximize T2 or T2* BOLD contrast at a given 
field strength while minimizing inherent disadvantages each technique carries with 
respect to artifacts and noise. 
 
The gradient-echo based approach to measure the myocardial BOLD effect was 
initially adapted from brain and skeletal muscle imaging protocols and has been 
demonstrated in vivo and ex vivo research at a variety of field strengths (10,24).  
Using increasingly available clinical 3T magnets, GRE techniques suffer 
susceptibility artifacts at the heart-lung interface and at the posterior vein of the left 
ventricle (PVLV) (25,26). Spin-echo based approaches have generated some 
interest as they are relatively immune to this problem, but feature a limited 
potential for BOLD contrast and a slower rate of signal acquisition as compared to 
T2* measurement techniques (16,25,27). Cardiac imaging with SSFP techniques 
has recently become feasible due to advances in gradient performance (13,16,28). 
The BOLD effect, as measured via T2-prepped SSFP, is determined by a 
combination of proton density weighting, T1, and T2 effects.  SSFP offers good 
SNR and blood-myocardium contrast, but it is difficult to achieve control over T1 
effects and other artifacts at high field (13,29). 
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Since the advent of clinical 3T MRI, the inherent signal to noise advantage has 
been much publicized as driving the future of clinical cardiac care (5,8). However, 
increased SAR restrictions, susceptibility artifacts, and standing waves pose 
challenges not readily apparent at 1.5T.  Much effort has been expended 
developing phased array coils, new sequence techniques, navigator gating, and 
other methods to mitigate the disadvantages of thoracic imaging at 3T. Most 
clinical imaging utilizes delayed contrast enhancement and SSFP cine techniques 
to confirm the functional status of the heart (6,8). However, these sequences are 
not directly applicable to measuring the myocardial BOLD effect. Applying the 
knowledge gained improving clinical high-field imaging towards improving 
myocardial BOLD imaging has not been reported. 
 
The goal of the present work was to develop methods that overcome the practical 
difficulties of 3T human myocardial BOLD imaging and to determine reliable 
reference values for transverse relaxation times across normal human 
myocardium. It is of note that the typical protocol provided by the major MRI 
manufacturers for transverse relaxation mapping is a single 2-echo scan for in vivo 
measurement. Given only two data points to define an exponential decay, these 2-
echo protocols may not allow for reliable measurement of transverse relaxation 
(17,18). With the goal of reliably measuring transverse relaxation for use in 
myocardial BOLD imaging, a series of multi-echo, breath-hold scans were tested 
to optimize the measurement of T2 and T2* at 3 Tesla with resolution sufficient 
enough to distinguish endo- and epicardium. Accurate measurement of T2 and T2* 
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with these new techniques at high field will allow researchers to consistently detect 
subtle changes in tissue properties, yielding new insight into basic questions about 
cardiac physiology. 
 
Methods 
Nine healthy volunteers were recruited to investigate magnetic resonance tissue 
properties of normal myocardium. The average age for the six male and three 
female volunteers was 24.8 ± 1.6 years. Volunteers underwent safety screening 
and provided written informed consent to participate in the study. The local 
Institutional Review Board (IRB) approved the study protocol. Subjects were 
imaged in the supine position using a 3.0T MRI scanner with a six-channel cardiac 
imaging coil (Philips Achieva 3T, Philips Medical Systems, Best, NE). 
 
The imaging protocol began with an anatomic localizer and reference scan for 
parallel imaging. Short-axis views were established using a real-time slice planning 
sequence. To make the most uniform static magnetic field over the tissues of 
interest, shim volumes were prescribed to include the entire LV in plane and 
extending one centimeter on both sides of the imaging plane.  First and second 
order shimming was used.  Then, a series of turbo spin-echo and turbo field-echo 
scans were conducted as described below. Common to all scans was the use of 
triggered acquisition to place the imaging window during late diastole. Also, black-
blood double-inversion pre-pulses were used prior to each image acquisition to null 
signal from blood in the ventricles (14). To facilitate breath holding for slower 
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cardiac rates, most scans were limited to 15 cardiac cycles to keep the total scan 
time less than ~20 seconds. Subjects were instructed to hold their breath at a 
comfortable end expiratory position, functional reserve capacity (FRC), prior to the 
imaging session (30).  
 
Turbo Spin-Echo 
Three multi-echo turbo spin-echo (TSE) T2-measurement methods were tested. 
Each method involved tradeoffs between acquired data as measured by phase 
encoding (PE) lines per image versus number of echo-image sample points 
obtained along the T2 decay curve.  The first method utilized an interleaved pair of 
standard dual-echo TSE scans (2x2-echo), where in each scan fourteen echoes 
from the echo train were encoded for two TSE images. With seven lines acquired 
per image per cardiac cycle, and 15 cardiac cycles, this method yielded a total of 
105 phase encoding lines per image. Low spatial frequency phase encoding lines 
were acquired first (i.e., “low-high” profile order), and effective echo times were 20 
and 60 ms for the first scan and 40 and 80 ms for the second scan. The same 
transmitter and receiver gains were used for each scan to eliminate arbitrary signal 
scaling.  Further scan details are summarized in Table 1. 
11 
 
The second method investigated was a single, custom-designed TSE scan where 
16 echoes from the echo train were encoded as four TSE images (4-echo TSE).  
Thus, the first four echoes were assigned to the first echo-image, the second set of 
four echoes to the second echo-image, and so on.  With an inter-echo spacing of 6 
ms and low-high profile order, this resulted in effective echo times of: 6, 30, 54, 
and 78 ms. See Table 1 for details. An illustration of this echo train division is given 
in Figure 1.  
 
The third method investigated was a single, custom-designed TSE scan where, 
similar to the 4-echo TSE method, 16 echoes from the echo train were encoded as 
eight TSE images (8-echo TSE). Thus, the first two acquired echoes are assigned 
to the first echo-image, and then the next two acquired echoes are assigned to the 
second echo-image, and so forth.  With inter-echo spacing of 6 ms and a low-high 
profile order, this method resulted in echo times of: 6, 18, 30, 42, 54, 66, 78, and 
90 ms. A summary of the features of each method are given in Table 1.   
Flip Angle  90           160                        160                          160                         160            
RF  
Slice  
Phase  
Readout  
Echo Grouping  
Figure 1: Sample ME TSE sequence.  The blue bar at bottom indicates 4-echo grouping.  Red 
bars indicate 8-echo grouping. 
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Parameters common to all TSE methods include: TR = 1 RR interval, FOV = 320 x 
256 mm, matrix interpolation to 256 x 256, slice thickness = 6mm, excitation flip 
angle = 90°, refocusing flip angle = 160°, half-scan = 0.8, scan percent = 0.8 and 
parallel imaging (SENSE (31, 32)) reduction factor = 1.5.  
 
Table 1: TSE Methods 
 
Turbo Field-Echo 
Three multi-echo turbo field-echo (TFE) T2*-measurement methods were tested. 
These methods were designed to highlight the differences between achievable 
bandwidth per pixel and echo time constraints versus the number of sample points 
obtained along the T2* decay curve. Minimum bandwidth between pixels was 
desired to minimize the effects of electronic or thermal noise generated by the 
scanner (33). As the inter-echo spacing was decreased, the water-fat shift 
parameters (1/ pixel bandwidth) (2) had to be correspondingly reduced, resulting in 
larger pixel bandwidths as the number of acquired echoes increased. The first 
method used was a series of three dual-echo TFE sequences. The first echo was 
fixed at 2.3 ms and second echoes were set at 6.9, 11.5, and 18.4 ms, resulting in 
TSE Method RO Points TSE 
Factor 
Shots 
(cardiac 
cycles) 
PE Lines / 
Image 
Pixel BW 
(Hz) 
2 x 2-echo 256 14 15 x 2 105 352 
4-echo 256 16 15 60 294 
8-echo 256 16 22 44 291
13 
Figure 2: Sample 4-echo TFE sequence.  Four echoes are acquired per alpha excitation. The blue region 
indicates the four acquired echo times.       
a total of four unique time point samples along the T2* decay curve. The same 
transmitter and receiver gains were used for each scan. Minimum pixel bandwidth 
achievable was 294.3Hz/pixel. A four-echo TFE sequence was then used with the 
first echo set at 2.3 ms and subsequent echoes incremented, in-phase, up to 16.1 
ms with a fixed ΔTE of 4.6 ms, resulting in four decay curve samples.  Minimum 
pixel bandwidth was also scanner limited to 294.3Hz/pixel. This sequence is 
illustrated in Figure 2.  
 
The last method utilized an eight-echo TFE sequence with the first echo set at 2.3 
ms and later echoes incremented, in-phase, up to 18.4 ms with a ΔTE of 2.3 ms, 
resulting in eight decay curve samples. Here the short ΔTE required the use of a 
minimum pixel bandwidth of 482.5Hz/pixel. A summary of these features is given 
in Table 2.  
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provided the lowest variance of mean T2 values across subjects. The 4-echo 
method gave the best curve fits, with the highest reported R2 average value of 
0.983. The difference in quality of monoexponential curve fits between the 2x2- 
and 4-echo methods and the 4- and 8-echo methods were significant as compared 
using the student’s t-test (p = 0.0004, p = 0.023 respectively). The R2 values 
compared between the 2x2- and 8-echo methods were not considered significantly 
different. The highest average SNR reported for T2 measurement was given by 
the 8-echo method, however the differences in means and variances of SNR 
across all techniques were not significant. The 2x2-echo method gives the best 
acquired resolution as compared to the 4- and 8-echo methods.  
 
One-way ANOVA revealed no statistical difference in reported standard deviations 
for mean T2* values compared across subjects and, a student’s t-test comparing 
the TFE methods showed no statistical differences in the reported means. The 4-
echo method of T2* measurement provided the smallest standard deviations of 
mean T2* values across subjects. The 4-echo method yielded the best curve fits, 
with the highest reported R2 average value of 0.949. The differences in quality of 
monoexponential curve fits between the 3x2- vs. 4-echo and the 4-echo vs. the 8-
echo methods were significant (p = 0.007 and p = 0.043 respectively). The R2 
values compared between the 3x2- and 8-echo methods were not considered 
significantly different. The highest average SNR reported for T2* measurement 
was given by the 8-echo method; however the differences in means and variances 
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of SNR across all techniques were not significantly different. All TFE methods 
resulted in the same acquired voxel size.  
 
Endo- and epicardial ROIs showed a statistically significant difference in mean T2* 
(p = 0.05) with the endocardial T2* ROI being less than the epicardial T2* ROI. 
There was no significant difference in mean T2 measured across the myocardium. 
Whole LV analysis of T2 and T2* was prohibited by uncompensated susceptibility 
effects and other artifacts that appeared in varying regions from subject to subject 
in the free wall of the LV.  
Table 3: TSE results across subjects in the mid-ventricular septum (N = 9). 
*p<0.05 
Table 4: TFE results across subjects in the mid-ventricular septum (N = 9). 
*p<0.05 
TSE Method Average T2 (ms) 
across subjects 
Stdev. of 
T2 (ms) 
Avg. curve 
fit R2 
SNR in 
septum 
2x2-echo 57.6 9.1 0.971 10.6 
4-echo 61.6 7.8 0.983 14.8 
8-echo 58.5 7.0 0.971 15.0 
Average across 
all methods 
59.5 7.9 0.976 13.8 
TFE Method Average T2* 
(ms) across 
subjects 
Stdev. of T2* 
(ms) 
Avg. curve fit 
R2 
SNR in 
septum 
3x2-echo 31.6 13.1 0.919 11.7 
4-echo 31.2 9.6 0.949 11.6 
8-echo 32.2 10.3 0.917 9.0 
Average across 
all methods 31.6 6.1 0.929 10.1 
* 
* 
* 
* 
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compared to the 2x2-echo series. Even so, SNR increases slightly from the 2x2-, 
to 4-, to 8-echo methods. This is presumably due to differences in echo times 
along with the effects of increasing voxel size overwhelming the effects of phase 
encode line reduction. Thus, the reported SNR values may be considered only a 
general measure of image quality for loose comparison among methods.  
 
Given that the typical in-plane resolution for the 2x2-echo method was 1.25x1.6 
mm2, this method resulted in the highest spatial resolution scans and thus gave 
the sharpest images.  By sacrificing the number of phase encoding lines acquired 
for additional temporal sampling of the T2 decay curve, the 4- and 8-echo methods 
resulted in more elongated voxels, typically 1.25x3.2mm2 and 1.25x4.6mm2 
respectively. Given this, partial volume effects became apparent as softened 
borders along tissue boundaries. See Figure 6 above. 
 
Image artifacts were generally confined to the free wall of the left ventricle. It is 
hypothesized that a major source of image variation in this area was due to 
uncompensated susceptibility effects. These effects are presumably due to the use 
of 160° refocusing pulses instead of the 180° pulses typically prescribed in 
modified Carr-Purcell-Meiboom-Gill (CPMG) experiments (17). Imperfect 
refocusing of transverse magnetization at the long echo times measured here as 
compared to T2 may account for these susceptibility effects being more apparent 
than in the gradient-echo methods (36). Along with the susceptibility effects, other 
general sources of image artifacts are imperfect breath holding or cardiac motion 
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during the acquisition window. Given that the 4-echo method had similar image 
characteristics to the 8-echo, but allowed for higher resolution scans,  
demonstrated the best curve fits, and required only a single breath hold, the 4-
echo method is recommended over the 8-echo method.  
  
Measured T2* values were very consistent both in reported means and in SNR 
across the three scan methods. This reveals that any of the scan methods may be 
used to generate consistent T2* values. However it is worth noting that even with 
the similar SNR among the TFE series, significant decreases in the standard 
deviation of the T2* value and increases in the quality of fit (R2) exist favoring the 
4-echo method. It is also advantageous to acquire data in a single breath hold, 
shifting preference away from the 3x2-echo method. Given the above evidence the 
4-echo method is recommended for measuring T2*.  
 
The reported mean T2* value of 31.6 ± 6.1 ms is consistent with other published 
values. Recent research at 3T reports values for T2* in vivo as 27.3 ± 6.4ms (37) 
and 33.3 ± 2.7 ms (38).  It is important to note that all TEs utilized in the TFE scans 
were shorter than the measured T2* values.  Ideally TEs should be spaced on 
either side of the measured value, with emphasis placed on measuring early TEs 
(18). However, image degradation noted beyond the latest measured echo time 
(18.4 ms) was so severe at 3T as to preclude extending temporal sampling.   
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TFE images showed less variation in image quality as the number of echoes 
increased compared to the TSE series. This was expected due to the fact that all 
three TFE methods used the same number of phase encoding lines (see Table 2). 
Unlike in the TSE images, here the SNR results may be directly compared due to 
the images carrying the same first echo times. The TFE SNR was mainly expected 
to vary as a result of minimum achievable pixel bandwidth; however there was no 
significant difference measured in SNR across methods.  
 
Image artifacts in the TFE scans were affected 
by the same physiologic noise seen in the TSE 
methods, including poor breath-hold motion 
suppression, cardiac motion during acquisition, 
in addition to susceptibility artifacts that are 
characteristic of gradient-echo based 
sequences. This phenomenon is observed 
especially at boundaries of tissue with large 
differences in magnetic susceptibility, such as 
at the heart-lung interface and around the posterior vein of the left ventricle (25) 
(26). These artifacts can be seen in the free wall of the left ventricle in Figure 7 
above. Similar artifacts limited more comprehensive free wall and whole ventricle 
signal analysis. 
 
 
Figure 7: First echo image of a 2-echo 
TFE sequence.  The arrow points to a 
susceptibility artifact at the heart-lung 
interface. 
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High resolution 4-echo scans were utilized to facilitate the measurement of 
potential endo- and epicardial signal gradients. The techniques described here 
yield voxel sizes well below other recent investigations at 3T (16,22,37). Endo- and 
epicardial ROIs were investigated for observed gradients due to differences in 
transmural myocardial perfusion. It is of particular note that the observed change in 
signal for T2* was in the opposite direction as predicted by previous theoretical 
(12) and oxygen-dependant studies (22,39). Much of that research focuses on 
observed changes as a result of myocardial infarction, not on any inherent T2* 
gradient that may exist as a result of perfusion differences. As the endocardium is 
more hypoxic than the epicardium (11), the relative T2* should theoretically be 
lower in the endocardial ROI than in the epicardial ROI. The mismatch between 
the theoretically predicted higher T2* values in the epicardium and our results 
measuring lower T2* values may be partially explained by increased susceptibility 
effects in the free wall. These effects may have suppressed signal in the 
epicardium at longer TEs to the extent that curve fits to the pixels in this area 
resulted in significantly lower T2* measurements than expected (p = 0.04). The 
results for T2 measurement in the free wall did not show a significant difference in 
measured endo- and epicardial ROIs; however the trend for lower epicardial signal 
did follow the GRE measurements. These findings reveal the potential difficulty in 
using GRE based techniques for visualizing BOLD gradients in the free wall of the 
myocardium at 3T.  
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Ideally, a very large number of echoes would be used to accurately characterize 
transverse relaxation in vivo. However, unlike in NMR experiments, there are 
many issues limiting the amount of echoes that may be practically acquired in 
cardiac MRI. Typically, clinical imaging attempts to maximize SNR, decrease voxel 
size, and limit specific absorption rate (SAR) exposure. This methodology shifts 
available SNR and acquisition time away from accurately measuring tissue 
characteristics towards visualization of detailed anatomy both statically and 
dynamically (6, 40). However, the importance of utilizing the increased temporal 
and SNR gains available with high-field magnets to more precisely characterize 
endogenous contrast mechanisms must not be minimized. The high quality of 
curve fits reported here reflects the accuracy of the measured transverse 
relaxation values. There is unfortunately no gold standard for in vivo cardiac tissue 
T2 or T2* measurement, therefore comparison to other published results in terms 
of reported means and variance may be the only general measure of accuracy. It 
is important to further investigate these techniques for use in cardiac research 
describing the myocardial BOLD effect, perfusion tests, and other aspects of 
oximetry. 
 
This study was limited in part by the small number, relative youth, and health of the 
available volunteers.  Two-echo methods were not investigated as they have been 
in wide use for estimating transverse relaxation for some time (10,14). Inherent in 
a 2-echo design is an overly simplistic two point fit to an exponential decay curve, 
and this would have precluded quality of curve fit comparison to the multi-echo 
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methods described here  (17,18). The use of newly developed 3rd order shim tools 
that have been applied in SSFP imaging (28) should improve future results. It 
would also be of interest to investigate these techniques in combination with 
navigator gated acquisition, allowing for signal averaging over extended periods of 
time.   
 
In conclusion, this work at 3T demonstrates the feasibility of multi-echo sampling of 
T2 and T2* while maintaining adequate SNR and voxel sizes to investigate endo- 
and epicardial gradients. Given the inherent advantage in multi-echo temporal 
sampling of transverse relaxation over 2-echo methods, utilizing these techniques 
will be of importance when describing subtle differences in tissue relaxation. As it 
is of continued importance to characterize myocardial oximetry non-invasively it is 
imperative to have the most accurate sequences available for this type of 
measurement. These results suggest that the 4-echo methods are best suited for 
optimal T2 and T2* sampling in the mid-ventricular septum. This work presents 
reliable, high spatial resolution techniques for measuring T2 and T2* and provides 
reference values for transverse relaxation times in the normal myocardium.
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CHAPTER III 
 
CONCLUSIONS AND FUTURE WORK 
 
This work at 3T demonstrates the feasibility of multi-echo sampling of T2 and T2* 
while maintaining adequate SNR and voxel sizes to investigate endo- and 
epicardial gradients. Given the inherent advantage in multi-echo temporal 
sampling of transverse relaxation over 2-echo methods, utilizing these techniques 
will be of importance when describing subtle differences in tissue relaxation. As it 
is of continued importance to characterize myocardial tissue non-invasively, it is 
imperative to have the most reliable and reproducible sequences available for this 
type of measurement. These results suggest that the 4-echo methods are best 
suited for optimal T2 and T2* sampling in the mid-ventricular septum. This work 
presents reliable, high spatial resolution techniques for measuring T2 and T2* and 
provides reference values for transverse relaxation times in the normal 
myocardium. 
 
Future work will build on these results by adding the use of newly developed 3rd 
order shim tools that have been recently applied to SSFP imaging (28). The 
addition of this technique should improve future results by compensating for 
susceptibility gradients at the heart-lung interface. The optimal method proposed 
above will be tested for improved consistency of results utilizing the shim tools.  
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It would also be of great interest to modify these techniques for use with navigator 
gated acquisition. Navigator gating would allow for signal averaging in 
measurements over extended periods of time. Free breathing during navigator 
acquisition would also be of use when investigating subjects with pathology, as 
they are presumably less capable of maintaining an extended breath hold. 
 
The high quality of curve fits reported here reflects the accuracy of the measured 
transverse relaxation values. There is unfortunately no gold standard for in vivo 
cardiac tissue measurement, therefore comparison to other published results in 
terms of reported means and variance may be the only general measure of 
accuracy. It is important to further investigate these techniques for use in cardiac 
research describing the myocardial BOLD effect, perfusion tests, and other 
aspects of oximetry.  
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APPENDIX 
 
MATLAB Code  
Description: This MATLAB code calculates T2 and T2* maps from multi-echo TSE 
and TFE source files taken from Philips Achieva series clinical MRI scanners.  File 
handling, ROI selection, SNR, and curve fitting functions are all performed. Co-
registration of images is implemented, but is currently commented out for this 
study as they images were well registered by the Philips console software 
(v.2.1.3).    
%Calc ME Cardiac Signal to Noise Ratio 
%Written by Jared Cobb 
%VUIIS: Vanderbilt University 
%Copyright 2008 
%Version: 1/25/08 
%Requires: PARMfromPAR_3Ta.m, vuOpenImage.m 
  
  
clc;clear all;close all; 
  
% COBBJG : START FILE HANDLING 
  
%Open First File 
file = vuOpenImage; 
  
%Get filename 
filename = file.Parms.filename; 
scanNum = file.Parms.acq_nr; %get scan number 
%Get Dimensions 
[nRows nCols numEcho] = size(file.Data);  
%Get scan method, T1TFE or TSE 
method = file.Parms.technique; 
data = file.Data; 
  
%COBBJG : END FILE HANDLING 
  
% COBBJG : SET / GET ECHO TIMES : CONVERT TO FUNCTION 
if strcmp(method,'TSE') 
    if numEcho == 4 
        echoes = [6 30 54 78]'; 
        scanEchoes = numEcho; 
    elseif numEcho == 8 
        echoes = [6 18 30 42 54 66 78 90]'; 
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        scanEchoes = numEcho; 
    end 
end 
if strcmp(method,'T1TFE') 
        echoes = PARMfromPAR_3Ta(filename,31); 
        scanEchoes = numEcho; 
end 
% COBBJG : END GET ECHO TIMES : CONVERT TO FUNCTION 
  
% COBBJG : 2x2E TSE case 
  
if (strcmp('TSE',method) && (numEcho == 2)); 
    file2 = vuOpenImage; 
  
    %Get filename 
    filename2 = file2.Parms.filename; 
    scanNum2 = file2.Parms.acq_nr; %get scan number 
    %Get Dimensions 
    [nRows2 nCols2 numEcho2] = size(file2.Data); 
    %Get Echo Times 
    echoes = PARMfromPAR_3Ta(filename,31); 
    echoes2 = PARMfromPAR_3Ta(filename2,31); 
    %Get scan method, T1TFE or TSE 
    method2 = file2.Parms.technique; 
  
    if (strcmp(method,method2) == 0) 
        'FILE TYPES TO NOT MATCH' 
    end 
  
    %reorder data 
    data = zeros(nRows,nCols,4); 
    data(:,:,1) = file.Data(:,:,1); %20ms 
    data(:,:,3) = file.Data(:,:,2); %60ms 
    data(:,:,2) = file2.Data(:,:,1); %40ms 
    data(:,:,4) = file2.Data(:,:,2); %80ms 
  
    echoes = [echoes(1);echoes2(1);echoes(2);echoes2(2)]; 
    numEcho = 4; 
    scanEchoes = 2; 
end 
% COBBJG : End 2E TSE case 
  
% COBBJG : Start 3x2E TFE case 
  
if (strcmp('T1TFE',method) && (numEcho == 2)); 
    file2 = vuOpenImage; 
    file3 = vuOpenImage; 
  
 %Get filenames 
    filename2 = file2.Parms.filename; 
    filename3 = file3.Parms.filename; 
    scanNum2 = file2.Parms.acq_nr; %get scan number 
    scanNum3 = file3.Parms.acq_nr; 
    %Get Dimensions 
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    [nRows2 nCols2 numEcho2] = size(file2.Data); 
    [nRows3 nCols3 numEcho3] = size(file3.Data); 
    %Get Echo Times 
    echoes = PARMfromPAR_3Ta(filename,31); 
    echoes2 = PARMfromPAR_3Ta(filename2,31); 
    echoes3 = PARMfromPAR_3Ta(filename3,31); 
    %Get scan method, T1TFE or TSE 
    method2 = file2.Parms.technique; 
    method3 = file3.Parms.technique; 
  
    if (strcmp(method,method2) == 0) 
    'FILE TYPES TO NOT MATCH' 
    end 
     
    %reorder data 
    data = zeros(nRows,nCols,4); 
    data(:,:,1) = file.Data(:,:,1); %2.30ms 
    data(:,:,2) = file.Data(:,:,2); %6.91ms 
    data(:,:,3) = file2.Data(:,:,2); %11.51ms 
    data(:,:,4) = file3.Data(:,:,2); %18.41ms 
  
    scale = zeros(nRows,nCols,3); 
    scale(:,:,1) = file.Data(:,:,1); %2.3 ms Data for scaling 
    scale(:,:,2) = file2.Data(:,:,1); 
    scale(:,:,3) = file3.Data(:,:,1); 
     
    echoes = [echoes(1);echoes(2);echoes2(2);echoes3(2)]; 
    numEcho = 4; 
    scanEchoes = 2; 
     
end 
  
% COBBJG : END 3x2E TFE case 
  
% COBBJG : START SIGNAL MASK 
  
cmap = contrast(data(:,:,1)); %adjust Contrast / Brightness 
figure(1) 
imagesc(data(:,:,1)); %scales data to colormap and displays pic 
zoom(2) 
title('Select Cardiac *Signal* ROI') 
colormap(cmap) 
SignalMask = roipoly; %roipoly selects region of interest 
  
% COBBJG : Implement if not co-registered well. 
% if numEcho3 == 2 
%    % cmap = contrast(data(:,:,3)); 
%     figure(2) 
%     imagesc(data(:,:,3)); 
%     zoom(2) 
%     colormap(cmap) 
%     title('Select second Cardiac Signal ROI') 
%     SignalMask2 = roipoly; 
%     cmap = contrast(data(:,:,4)); 
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%     figure(3) 
%     imagesc(data(:,:,4)); 
%     zoom(2) 
%     colormap(cmap) 
%     title('Select third Cardiac Signal ROI') 
%     SignalMask3 = roipoly; 
% end 
% COBBJG : END co-register 
  
%init ROI 'Signal' and mult by SignalMask from above 
Signal = zeros(nRows,nCols,numEcho);  
for i = 1:numEcho 
    Signal(:,:,i) = SignalMask .* data(:,:,i); 
end 
  
% COBBJG : SCALE DATA TO FIRST ECHO 
%only occurs in 3x2echo case (I hope!!!!!!!!!!!!!!!!!!!!!) 
if echoes(4) == 18.41 %must match 4th echo time exactly! 
    ScaleMask = zeros(nRows,nCols,3); 
    for i = 1:3 
    ScaleMask(:,:,i) = SignalMask .* scale(:,:,i); %ROI of all first 
echoes 
    end 
    a = ScaleMask(:,:,1); 
    aa = mean(mean(a(a>0)));%mean of 1st scan 2.3ms ROI 
    b = ScaleMask(:,:,2); 
    bb = mean(mean(b(b>0)));%mean of 2nd scan 2.3ms ROI 
    c = ScaleMask(:,:,3); 
    cc = mean(mean(c(c>0)));%mean of 3rd scan 2.3ms ROI 
    %In theory all these means match.  Scale bb and cc to match aa. 
    %scale echoes 3 & 4 to match echo 1 & 2. 
    Signal(:,:,3) = Signal(:,:,3) .* aa/bb; 
    Signal(:,:,4) = Signal(:,:,4) .* aa/cc; 
end 
% COBBJG : END SCALE DATA 
  
% COBBJG : END SIGNAL MASK 
  
  
% COBBJG : START NOISE MASK 
figure(2) 
imagesc(data(:,:,1)) %scales data to colormap and displays pic 
title('Select Cardiac *Noise* ROI') 
%colormap(gray) 
NoiseMask = roipoly; %roipoly selects region of interest 
  
Noise = zeros(nRows, nCols, numEcho); 
for i = 1:numEcho 
    Noise(:,:,i) = NoiseMask .* data(:,:,i); 
end 
% COBBJG : END NOISE MASK 
  
% COBBJG : Calc values for SNR 
warning off all 
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for i = 1:numEcho 
    X = Signal(:,:,i); 
    Y = Noise(:,:,i); 
    StdSig(i) = std(X(X>0)); %Std of Signal, no zeros included 
    MeanSig(i) = mean(X(X>0)); %Mean of Signal 
    StdNoise(i) = std(Y(Y>0)); %Std of Noise 
    MeanNoise(i) = mean(Y(Y>0)); %Mean of Noise 
end 
warning on all 
% COBBJG : END Calc SNR values 
  
% COBBJG : Start T2/T2* Map for whole image 
  
%create threshold mask 
firstImage_m = squeeze(data(:,:,1)); 
maxValue = max(firstImage_m(:)); 
mask_m = (firstImage_m > 0.05 * maxValue); % 5% or 10% mask 
figure, imagesc(mask_m);  %display mask 
  
warning off all 
t2_m = zeros(nRows, nCols); 
s0_m = zeros(nRows, nCols); 
R_m = zeros(nRows,nCols); 
t2lim = 500;  %upper limit based on type o scan. 
if (strcmp( 'TSE' , method)) 
    t2lim = 200; 
end 
if (strcmp( 'T1TFE' , method)) 
    t2lim = 100; 
end 
for row = 1:nRows 
    for col = 1:nCols 
        if (mask_m(row,col) == 1) 
            signal_v = squeeze(data(row, col, :)); 
            coeff_v = polyfit(echoes, log(signal_v), 1); 
            slope = coeff_v(1); 
            logS0 = coeff_v(2); % Intercept. 
            fit = polyval(coeff_v, echoes); 
            R_squared = corrcoef(signal_v, fit); 
            t2 = -1 / slope; 
            % Force a lower limit on the slope: 
            if (t2 > t2lim) 
                t2 = t2lim; 
            end 
            if (t2 < 0) 
                t2 = 0; 
            end 
            %end slope limit 
            t2_m(row,col) = t2; 
            s0_m(row,col) = exp(logS0); 
            R_m(row,col) = R_squared(2); 
        end 
    end 
end 
warning on all 
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% COBBJG : End T2/T2* Map 
  
% COBBJG : Calc Map values 
  
MapMean_m = SignalMask .* t2_m; 
RMean_m = SignalMask .* R_m; 
T2Mean = mean(MapMean_m(MapMean_m>0)); 
T2Std = std(MapMean_m(MapMean_m>0)); 
RMean = mean(RMean_m(RMean_m > 0)); 
RStd = std(RMean_m(RMean_m > 0)); 
  
% COBBJG : End Calc Map values 
  
% COBBJG : Convert num to str for display 
if strcmp( 'TSE' , method) 
    TC_name = 'T2'; 
elseif strcmp( 'T1TFE', method ) 
    TC_name = 'T2*'; 
else TC_name = 'Not a T1TFE or TSE Scan!'; 
end 
time_const = -1/slope; 
TC = num2str(time_const); 
SN = num2str(StdNoise); 
MN = num2str(MeanNoise); 
MS = num2str(MeanSig); 
SS = num2str(StdSig); 
%SNR = MeanSig ./ MeanNoise; 
SNR = MeanSig / StdNoise; 
SNR_text = num2str(SNR); 
  
% COBBJG : END num2str 
  
% COBBJG : Print Relevant Parms to Console 
file.Parms.patient 
echoes 
scanEchoes 
T2Mean 
T2Std 
RMean 
RStd 
SNR 
close all; 
figure 
imagesc(t2_m); 
colorbar; 
colormap(gray) 
title([TC_name,'Map']) 
zoom(2) 
xlabel('coordinates (pix)'), ylabel('coordinates (pix)') 
%SigMask2 = roipoly; 
% COBBJG : END PRINT 
  
% COBBJG : construct data and text to send to Excel 
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xlsfile = 'C:/Documents and Settings/cobbjg/My 
Documents/MATLAB/Cobb_Cardio_SNR.xlsx'; 
[NUMERIC,TXT,RAW]=XLSREAD(xlsfile); 
  
%find next row to append in file 
[xx,yy] = size(RAW); 
zz = xx(1)+1; 
xxx = num2str(zz); 
xlsrow = strcat('A',xxx); 
  
firstrow = {file.Parms.patient, num2str(scanNum), [num2str(scanEchoes), 
' echo ', method]... 
    T2Mean, T2Std, RMean, RStd, SNR}; 
  
%success = xlswrite(xlsfile, firstrow, 'Raw_Data', xlsrow);  
%csvwrite('C:/Documents and Settings/cobbjg/My 
Documents/MATLAB/test.csv',firstrow(4:8)); 
  
% COBBJG : END Write to Excel 
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